Developing COVID-19’s Vaccines: Short Review

Authors

  • Raghda Alsayed Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq
  • Mohammed Kadhom Department of Environmental Science, College of Energy and Environmental Sciences, Alkarkh University of Science, Baghdad-Iraq
  • Israa Salman Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq
  • Tariq Albaker Merck Company, Baghdad-Iraq
  • Nany Hairunisa Department of Occupational Medicine, Faculty of Medicine, Universitas Trisakti, Jakarta-Indonesia
  • Husnun Amalia Department of Occupational Medicine, Faculty of Medicine, Universitas Trisakti, Jakarta-Indonesia
  • Emad Yousif Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq

Keywords:

COVID-19, SARS-CoV-2, Pandemic, RNA vaccine, Receptor-binding domain

Abstract

Background. Since humanity is attempting to challenge the COVID-19 pandemic by accelerating the production of vaccines against SARS-CoV-2, there could be opposite health side-effects on the participants and researchers. Materials and Methods: Institutions, governments, companies, and organizations around the world work relentlessly to produce drugs and/or vaccines for this disease; yet none were approved. In this work, we are presenting the technologies platforms, developed vaccines, development challenges, and the under-process vaccines. Results: The recent developments in the diagnosis and types of vaccines were also discussed. Conclusion: Many vaccines were invented to stop COVID-19’s spreading using different techniques.

 

Downloads

Published

2022-03-28

Issue

Vol. 25 No. 1 (2022): March

Section

Articles

How to Cite

[1]
“Developing COVID-19’s Vaccines: Short Review”, ANJS, vol. 25, no. 1, pp. 59–63, Mar. 2022, Accessed: May 02, 2024. [Online]. Available: https://anjs.edu.iq/index.php/anjs/article/view/2410

Most read articles by the same author(s)

1 2 3 4 > >>